The market for ischemia-reperfusion injury therapeutics is anticipated to expand at a CAGR of 6.2% during the forecast period of 2023 to 2031. Reperfusion injury, also known as Ischemia-Reperfusion Injury, is the tissue damage that occurs when blood supply returns to ischemic tissue. Increased tissue damage and fluid filtration across the tissue are the primary factors driving the market's expansion. During the forecast period, the demand for reperfusion injury is anticipated to be bolstered by an increase in market awareness and R&D expenditures. Ischemia-reperfusion injury (IRI) occurs when blood flow to a tissue area is blocked (ischemia) and then restored (reperfusion) (reperfusion). This may occur when a blood vessel is temporarily blocked and then reopened, such as during a heart attack, stroke, or surgery. Ischemia deprives the tissue of oxygen and nutrients, which may result in cell and tissue damage. When blood flow is restored (reperfusion), the sudden influx of oxygen can trigger a cascade of damaging reactions, including inflammation and the production of reactive oxygen species (ROS), resulting in additional tissue damage. This injury may result in structural and functional organ impairments, such as myocardial infarction, stroke, and kidney injury.
The global ischemia reperfusion injury therapeutics market is driven by an increase in the prevalence of cardiovascular diseases, an increase in the geriatric population, and an increase in healthcare professionals' and patients' awareness of ischemia-reperfusion injuries. Significant market opportunities exist for manufacturers as a result of technological advances and the creation of new and effective therapies. In addition, government initiatives and funding for research and development of new therapies contribute to market growth. The COVID-19 pandemic decreased the number of elective surgeries, resulting in a decrease in the number of ischemia-reperfusion injury cases. In addition, the pandemic reduced funding for research and development. However, the increased emphasis on COVID-19 treatments has led to discoveries and advancements that may one day aid in the treatment of ischemia-reperfusion injury. An increase in the number of patients requiring IRI treatment due to a rise in the incidence of cardiovascular diseases and organ transplants is driving market growth. The increase in healthcare expenditures and awareness of IRI treatment options are driving market expansion.
New Product Development to Drive the Market
The market is growing due to the development of new drugs and therapies that can effectively target and treat IRI, as well as the expansion of existing treatments into new indications. Increased incidence of IRI-related conditions, such as heart attack and stroke, is anticipated to stimulate the growth of the global ischemia reperfusion injury therapeutics market. The increase in the use of telemedicine and other digital technologies to improve patient outcomes and the development of new diagnostic tools present significant opportunities for industry companies.
Increase in Cardiovascular Disease Prevalence
Ischemia-reperfusion injury therapeutics market share is being driven by an increase in the patient population requiring IRI treatment due to the prevalence of cardiovascular diseases such as heart attack and stroke. Ischemia-reperfusion injury is a leading cause of tissue damage in patients with cardiovascular disease and may occur during certain medical procedures, including angioplasty. The demand for ischemia-reperfusion injury therapeutics is anticipated to be driven by an aging population and an increase in cardiovascular diseases risk factors, such as obesity and diabetes.
Globally, cardiovascular diseases (CVDs) are the leading cause of death. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, accounting for 17,9 million deaths annually. CVDs are becoming more prevalent as a result of the aging population and a rise in risk factors such as obesity and diabetes. In addition, CVDs are more prevalent in low- and middle-income countries with limited access to healthcare and preventive measures.
Increased Disease Awareness Among Health Care Professionals and Patients
An increase in healthcare professionals' and patients' awareness of IRI is driving the demand for effective treatments. Education and training are increasing healthcare professionals' awareness of this condition. This is likely to lead to an increase in diagnosis and treatment. Patients are now more knowledgeable about the condition and its possible complications. Increased awareness of IRI has led to an increase in research and development, as well as the introduction of several treatments for the condition.
IRI is becoming more well-known as a result of an increase in research and understanding of the mechanisms involved and potential interventions that could be used to mitigate its effects. In addition, the use of ischemia-reperfusion in a variety of clinical settings, such as organ transplantation and cardiopulmonary bypass surgery, has led to a rise in attention and understanding of the condition. In addition, the increasing popularity of regenerative medicine has led to a greater emphasis on the role of ischemia-reperfusion in tissue injury and repair. Increased awareness among healthcare professionals and patients is anticipated to drive demand for ischemia-reperfusion injury therapeutics over the forecast period.
Development of Innovative and Efficient Treatments
The development of new and effective therapies for ischemia-reperfusion injury that are more effective and have fewer side effects than existing therapies is anticipated to boost the market growth of ischemia-reperfusion injury therapeutics. This is likely to result in a rise in demand for these therapies and an increase in the companies' revenues. In addition, ongoing research and development in IRI therapeutics may result in the discovery of new targets and therapeutic mechanisms. This is expected to accelerate market expansion. The industry is anticipated to be propelled by the development of new and effective therapies, such as drugs that can target specific pathways or molecules involved in the injury process. For example, drugs that inhibit inflammation or oxidative stress could aid in reducing IRI-related tissue damage. The use of regenerative medicine techniques, such as stem cell therapy, to repair or replace damaged cells and tissues could result in the development of therapies that restore function to the affected area and reduce the risk of complications. In addition, new technologies such as remote monitoring and telemedicine are being utilized to enhance the diagnosis and treatment of IRI. Utilization of stem cells and exosomes, pharmacological agents such as statins and phosphodiesterase inhibitors, and remote ischemic preconditioning are recent advances in IRI treatment. Other promising research areas include the utilization of hyperbaric oxygen therapy and extracorporeal devices to remove harmful molecules from the blood.
The Drug Therapy Segment Dominates the Therapeutic Form Market
The drug therapy segment dominated the global ischemia reperfusion injury therapeutics market in terms of treatment in 2022. IRIs are typically treated with widely accepted and well-established pharmaceuticals. These medications, which target inflammation or oxidative stress, could reduce the damage caused by IRIs and improve patient outcomes. In addition, the development of new, more effective treatments for IRI is ongoing. This is anticipated to propel the drug therapy market in the coming years.
In 2022, the Segment BAY-606583 Held the Largest Share of the Product Market
BAY-606583 is an adenosine receptor that is used to protect the heart and kidney of test animals from ischemia and to reduce myocardial reperfusion injury. Additionally, it is beneficial for treating acute lung and brain injuries. Given at reperfusion following 30 minutes of myocardial ischemia, GS-459679 inhibited caspase-3 in heart tissue 60 minutes after reperfusion injury. APP-103 is a poly oxalate-based copolymer molecule that reduces tissue injury and ischemia-reperfusion injury. It is a novel, non-toxic, and site-activating therapeutic approach that effectively mitigates ischemia-reperfusion injury in solid organ transplantation.
The Therapeutic Hypothermia Segment Dominated the Market by Treatment
The Therapeutic Hypothermia segment held the largest share of the reperfusion injury market in 2022 and is projected to grow at a CAGR of 5.5 % over the forecast period of 2023-2031, owing to its use for cardiac arrest patients. It improves newborn survival and reduces brain damage after birth asphyxia, nearly doubling the likelihood of normal survival. It helps to moderate intracranial pressure, reduce the harmful effect of a patient's inflammatory immune responses during reperfusion injury, and reduce the patient's production of potentially lethal free radicals during reperfusion injury. Reperfusion Injury causes biochemical imbalances within the cell that result in cell death and enlargement of the infarct, which is reduced by cyclosporin treatment, which rescues ischemic myocardium and decreases infarct size. Therapeutic hypothermia is anticipated to be the segment of the reperfusion injury market with the highest growth rate during the forecast period.
North America Remains as the Global Leader
In 2022, North America dominated the worldwide ischemia reperfusion injury therapeutics market. The region has a high incidence of IRI due to the high prevalence of cardiovascular diseases and the high number of surgical procedures performed. Additionally, North America's well-established healthcare infrastructure allows for early diagnosis and treatment of IRI. Governments in the region support the development and promotion of new IRI treatments through research and development funding and incentives. Patients' access to advanced treatments and technologies contributes to the growth of the market in North America, as do high healthcare expenditures. During the forecast period, the Asia-Pacific market is anticipated to expand rapidly. This is attributable to an increase in the elderly population, which is more susceptible to IRI, as well as an increase in public and professional awareness. The expansion of healthcare infrastructure and the availability of more advanced medical technologies contribute to the regional market expansion. In addition, an increase in the number of surgical procedures and a greater emphasis on organ transplantation drive the Asia-Pacific market.
New Product Innovations and Strategic Innovations to Impact the Market Shares
Included among these are Amyndas Pharmaceuticals LLC, Angion, Bolder Biotechnology, Opsona Therapeutics Ltd., Pharming Group NV, Prolong Pharmaceuticals, Prothix BV, Stealth BioTherapeutics, Inc., SBI Pharmaceuticals, Faraday Pharmaceuticals, Zealand Pharma A/S. To expand their market presence, these companies engage in mergers and acquisitions, strategic partnerships, and the introduction of new products.
- SBI Pharmaceuticals and the University of Oxford announced in March 2022 that the former had initiated a phase II clinical trial to develop a cardioprotective agent combining 5-ALA hydrochloride and sodium ferrous citrate for the mitigation of IRI in response to cardiac surgery under cardiopulmonary bypass. According to the clinical trial sponsorship agreement, both parties sponsor the trial.
- In November 2019, Faraday Pharmaceuticals announced the progression of FDY-5301's phase II clinical trials. It is a patented, sodium iodide-containing, elemental reducing agent. It destroys hydrogen peroxide, which is produced naturally as a result of acute ischemia-reperfusion injury and contributes to muscle function and mass loss. The drug is being developed as a treatment for ischemia-reperfusion injury resulting from a STEMI heart attack.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Ischemia Reperfusion Injury Therapeutics market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- A number of end users and consumption volume, price, and value.
- Geographical revenues generated by countries considered in the report
- Micro and macro environment factors that are currently influencing the Ischemia Reperfusion Injury Therapeutics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Product
- BAY-606583
- GS-459679
- APP-103
- KN-93
- Others
Injury Type
- Heart Injury
- Kidney Injury
- Intestine Injury
- Others
Treatment
- Therapeutic Hypothermia
- Cyclosporin
- Stem Cell Therapy
- Hydrogen Sulphide Treatment
- Others
Treatment Form
- Drug Therapy
- Medicated Gases
- Others
End-user
- Hospitals
- Specialty Clinics
- Others
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Ischemia Reperfusion Injury Therapeutics market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Ischemia Reperfusion Injury Therapeutics market?
- Which is the largest regional market for Ischemia Reperfusion Injury Therapeutics market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Ischemia Reperfusion Injury Therapeutics market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Ischemia Reperfusion Injury Therapeutics market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Ischemia Reperfusion Injury Therapeutics Market
2.2. Global Ischemia Reperfusion Injury Therapeutics Market, By Product, 2022 (US$ Million)
2.3. Global Ischemia Reperfusion Injury Therapeutics Market, By Injury Type, 2022 (US$ Million)
2.4. Global Ischemia Reperfusion Injury Therapeutics Market, By Treatment, 2022 (US$ Million)
2.5. Global Ischemia Reperfusion Injury Therapeutics Market, By Treatment Form, 2022 (US$ Million)
2.6. Global Ischemia Reperfusion Injury Therapeutics Market, By End-user, 2022 (US$ Million)
2.7. Global Ischemia Reperfusion Injury Therapeutics Market, By Geography, 2022 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2022
3. Ischemia Reperfusion Injury Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Ischemia Reperfusion Injury Therapeutics Market Vendors
3.2. Strategies Adopted by Ischemia Reperfusion Injury Therapeutics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Ischemia Reperfusion Injury Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Ischemia Reperfusion Injury Therapeutics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. BAY-606583
5.3.2. GS-459679
5.3.3. APP-103
5.3.4. KN-93
5.3.5. Others
6. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Heart Injury
6.3.2. Kidney Injury
6.3.3. Intestine Injury
6.3.4. Others
7. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Therapeutic Hypothermia
7.3.2. Cyclosporin
7.3.3. Stem Cell Therapy
7.3.4. Hydrogen Sulphide Treatment
7.3.5. Others
8. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Drug Therapy
8.3.2. Medicated Gases
8.3.3. Others
9. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2022 Versus 2031
9.3. Market Segmentation
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Others
10. North America Ischemia Reperfusion Injury Therapeutics Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
10.3. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
10.4. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
10.5. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
10.6. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
10.7.Ischemia Reperfusion Injury Therapeutics Market: By Region, 2021-2031, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
10.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
10.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
10.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
10.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
10.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
10.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
10.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
10.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
10.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
10.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
10.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
10.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11. UK and European Union Ischemia Reperfusion Injury Therapeutics Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.3. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.4. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.5. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.6. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11.7.Ischemia Reperfusion Injury Therapeutics Market: By Region, 2021-2031, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11.7.1.5. France
11.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
11.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
11.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
11.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
11.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12. Asia Pacific Ischemia Reperfusion Injury Therapeutics Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.3. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.4. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.5. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.6. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12.7.Ischemia Reperfusion Injury Therapeutics Market: By Region, 2021-2031, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12.7.1.3. India
12.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.7.1.4.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.7.1.5.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
12.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
12.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
12.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
12.7.1.6.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
13. Latin America Ischemia Reperfusion Injury Therapeutics Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
13.3. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
13.4. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
13.5. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
13.6. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
13.7.Ischemia Reperfusion Injury Therapeutics Market: By Region, 2021-2031, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
13.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
13.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
13.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
13.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
13.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
13.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
13.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
13.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
13.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
13.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
13.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
13.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
14. Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market, 2021-2031, USD (Million)
14.1. Market Overview
14.2. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
14.3. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
14.4. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
14.5. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
14.6. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
14.7.Ischemia Reperfusion Injury Therapeutics Market: By Region, 2021-2031, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
14.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
14.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
14.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
14.7.1.1.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
14.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
14.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
14.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
14.7.1.2.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Product, 2021-2031, USD (Million)
14.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Injury Type, 2021-2031, USD (Million)
14.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment, 2021-2031, USD (Million)
14.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By Treatment Form, 2021-2031, USD (Million)
14.7.1.3.1. Ischemia Reperfusion Injury Therapeutics Market: By End-user, 2021-2031, USD (Million)
15. Company Profile
15.1. Amyndas Pharmaceuticals LLC
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Angion
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Bolder Biotechnology
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Opsona Therapeutics Ltd.
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. Pharming Group NV
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Prolong Pharmaceuticals
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. Prothix BV, Stealth BioTherapeutics, Inc.
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. SBI Pharmaceuticals
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. Faraday Pharmaceuticals
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. Zealand Pharma A/S
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Others
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
List of Figures
Figure 1 Global Ischemia Reperfusion Injury Therapeutics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Ischemia Reperfusion Injury Therapeutics Market: Quality Assurance
Figure 5 Global Ischemia Reperfusion Injury Therapeutics Market, By Product, 2022
Figure 6 Global Ischemia Reperfusion Injury Therapeutics Market, By Injury Type, 2022
Figure 7 Global Ischemia Reperfusion Injury Therapeutics Market, By Treatment, 2022
Figure 8 Global Ischemia Reperfusion Injury Therapeutics Market, By Treatment Form, 2022
Figure 9 Global Ischemia Reperfusion Injury Therapeutics Market, By End-user, 2022
Figure 10 Global Ischemia Reperfusion Injury Therapeutics Market, By Geography, 2022
Figure 11 Market Geographical Opportunity Matrix - Global Ischemia Reperfusion Injury Therapeutics Market, 2022
Figure 12 Market Positioning of Key Ischemia Reperfusion Injury Therapeutics Market Players, 2022
Figure 13 Global Ischemia Reperfusion Injury Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 14 Global Ischemia Reperfusion Injury Therapeutics Market, By Product, 2022 Vs 2031, %
Figure 15 Global Ischemia Reperfusion Injury Therapeutics Market, By Injury Type, 2022 Vs 2031, %
Figure 16 Global Ischemia Reperfusion Injury Therapeutics Market, By Treatment, 2022 Vs 2031, %
Figure 17 Global Ischemia Reperfusion Injury Therapeutics Market, By Treatment Form, 2022 Vs 2031, %
Figure 18 Global Ischemia Reperfusion Injury Therapeutics Market, By End-user, 2022 Vs 2031, %
Figure 19 U.S. Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 20 Canada Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 21 Rest of North America Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 22 UK Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 23 Germany Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 24 Spain Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 25 Italy Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 26 France Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 27 Rest of Europe Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 28 China Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 29 Japan Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 30 India Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 31 Australia Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 32 South Korea Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 33 Rest of Asia Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 34 Brazil Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 35 Mexico Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 36 Rest of Latin America Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 37 GCC Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 38 Africa Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
Figure 39 Rest of Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 2 Global Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 3 Global Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 4 Global Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 5 Global Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 6 North America Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 7 North America Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 8 North America Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 9 North America Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 10 North America Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 11 U.S. Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 12 U.S. Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 13 U.S. Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 14 U.S. Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 15 U.S. Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 16 Canada Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 17 Canada Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 18 Canada Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 19 Canada Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 20 Canada Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 21 Rest of North America Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 22 Rest of North America Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 23 Rest of North America Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 24 Rest of North America Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 25 Rest of North America Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 26 UK and European Union Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 27 UK and European Union Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 28 UK and European Union Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 29 UK and European Union Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 30 UK and European Union Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 31 UK Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 32 UK Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 33 UK Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 34 UK Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 35 UK Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 36 Germany Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 37 Germany Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 38 Germany Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 39 Germany Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 40 Germany Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 41 Spain Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 42 Spain Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 43 Spain Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 44 Spain Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 45 Spain Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 46 Italy Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 47 Italy Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 48 Italy Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 49 Italy Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 50 Italy Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 51 France Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 52 France Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 53 France Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 54 France Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 55 France Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 56 Rest of Europe Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 57 Rest of Europe Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 58 Rest of Europe Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 59 Rest of Europe Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 60 Rest of Europe Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 61 Asia Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 62 Asia Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 63 Asia Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 64 Asia Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 65 Asia Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 66 China Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 67 China Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 68 China Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 69 China Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 70 China Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 71 Japan Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 72 Japan Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 73 Japan Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 74 Japan Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 75 Japan Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 76 India Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 77 India Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 78 India Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 79 India Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 80 India Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 81 Australia Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 82 Australia Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 83 Australia Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 84 Australia Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 85 Australia Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 86 South Korea Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 87 South Korea Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 88 South Korea Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 89 South Korea Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 90 South Korea Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 91 Latin America Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 92 Latin America Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 93 Latin America Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 94 Latin America Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 95 Latin America Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 96 Brazil Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 97 Brazil Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 98 Brazil Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 99 Brazil Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 100 Brazil Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 101 Mexico Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 102 Mexico Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 103 Mexico Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 104 Mexico Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 105 Mexico Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 106 Rest of Latin America Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 107 Rest of Latin America Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 108 Rest of Latin America Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 109 Rest of Latin America Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 110 Rest of Latin America Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 111 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 112 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 113 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 114 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 115 Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 116 GCC Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 117 GCC Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 118 GCC Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 119 GCC Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 120 GCC Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 121 Africa Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 122 Africa Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 123 Africa Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 124 Africa Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 125 Africa Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Table 126 Rest of Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Product, 2021-2031, USD (Million)
Table 127 Rest of Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Injury Type, 2021-2031, USD (Million)
Table 128 Rest of Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Treatment, 2021-2031, USD (Million)
Table 129 Rest of Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By Treatment Form, 2021-2031, USD (Million)
Table 130 Rest of Middle East and Africa Ischemia Reperfusion Injury Therapeutics Market By End-user, 2021-2031, USD (Million)
Companies Mentioned
- Amyndas Pharmaceuticals LLC
- Angion
- Bolder Biotechnology
- Opsona Therapeutics Ltd.
- Pharming Group NV
- Prolong Pharmaceuticals
- Prothix BV
- Stealth BioTherapeutics Inc.
- SBI Pharmaceuticals
- Faraday Pharmaceuticals
- Zealand Pharma A/S
